Genesis Therapeutics

Genesis Therapeutics is revolutionizing the biotech industry with its cutting-edge molecular AI platform designed for drug discovery. With a focus on unlocking novel protein targets and delving into previously untapped chemical space, the company accelerates the development of essential new medicines with unprecedented efficiency. At the heart of Genesis Therapeutics is a tight-knit team composed of skilled drug hunters, adept deep learning researchers, and innovative software engineers, all united in their mission to employ artificial intelligence for breakthroughs in biochemistry. Together, they create and develop innovative therapies aimed at treating severe disorders, providing hope and solutions for patients in need.

Key Features

• AI-Powered Drug Discovery: Leveraging advanced artificial intelligence to discover and develop new medications.

• Tight-Knit Expert Team: A collaborative group of seasoned drug hunters, deep learning scholars, and software engineers.

• Cutting-Edge Technology: Utilizing 3D spatial graph modeling and molecular simulation to create novel drug candidates.

• Impactful Partnerships: Notable collaborations with industry leaders like Eli Lilly and Roche's Genentech.

• Investment Confidence: Securing substantial funding, including a $200M Series B led by Andreessen and a partnership deal potentially worth $670M with Eli Lilly.

FAQ

What is the focus of Genesis Therapeutics?

Genesis Therapeutics is dedicated to leveraging artificial intelligence for drug discovery, targeting novel protein interactions and exploring new chemical spaces.

What investments and partnerships has Genesis Therapeutics secured?

In addition to Series B funding of $200M, Genesis Therapeutics has formed partnerships with Eli Lilly and Roche's Genentech, highlighting its significant role in the biotech industry.

How can one contact Genesis Therapeutics for business development or general inquiries?

Prospective employees, business developers, and general inquiries can reach out to Genesis Therapeutics via email at bd@genesistherapeutics.ai and info@genesistherapeutics.ai respectively.

Who comprises the team at Genesis Therapeutics?

The team is made up of drug discovery professionals, researchers specializing in deep learning, and skilled software engineers, working together to progress AI applications in biochemistry.

How does Genesis Therapeutics approach AI drug discovery?

Genesis Therapeutics uses a pioneering approach that combines 3D spatial graph modeling with state-of-the-art molecular simulation to identify and develop novel drug candidates.